Released: 11/30/2009
Expires: 11/30/2010

Target Audience
This activity was developed for oncology nurses and pharmacists who wish to enhance their knowledge concerning the treatment of patients with castration-resistant prostate cancer (CRPC).

Learning Objectives
At the completion of this activity participants should be able to:

• Describe the current standard of care for the treatment of CRPC/HRPC
• Review recent efficacy and safety data on the use of newer cytotoxic agents for CRPC/HRPC
• Describe the results of recent studies evaluating novel targeted agents for the treatment of CRPC/HRPC

Agenda - 1.5 hours
• Articles/Commentaries: 75 minutes
• Evaluation/Post-Test: 15 minutes

Registered Nurse Designation
Medical Learning Institute, Inc.
Provider approved by the California Board of Registered Nursing, Provider 15106, for 1.5 contact hours.

Registered Pharmacy Designation
MLI is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Completion of this activity provides for 1.5 contact hours (0.15 CEUs) of continuing education credit. The universal program number for this activity is 0468-9999-09-042-H01-P.

Instructions for Credit
There is no fee for this activity. To receive credit, participants must first take the pretest for this activity. After reading this CE activity in its entirety, participants must complete the posttest and evaluation. The pretest, posttest, and evaluation can be completed online at www.mlicme.org/p09063.html. Upon completion of the evaluation and scoring a 70% or better on the posttest, you will immediately receive your certificate online. If you do not achieve a score of 70% or better on the posttest, you will be asked to take it again. Please retain a copy of the Certificate for your records.

For questions regarding the accreditation of this activity, please contact Medical Learning Institute at (609) 333-1693 or cgusack@mlicme.org.

Disclosure Statement
Before the activity, all faculty will disclose theexistence of any financial interest and/or relationship(s) they might have with the manufacturer(s) of any commercial products(s) to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers’ bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions.

The associates of Medical Learning Institute, Inc. have no financial relationships to disclose. The associates of Center of Excellence Media, LLC, have no financial relationships to disclose.

Faculty Disclosures
Rebecca Elizabeth Greene, PharmD, BCOP has nothing to disclose.

Jeanne Held-Warmkessel, MSN, RN, AOCN®, ACNS-BC is on the advisory board for Merck, and is on the speaker's bureau for Cephalon and Novartis.


*Content will include non-FDA-approved uses.

Disclaimer
The information provided in this CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition.